New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure

被引:2
|
作者
McClelland, Sarah [1 ,2 ]
Zhou, Shuaiwei [1 ]
O'Connell, Eoin [1 ]
Gallagher, Joseph [1 ,2 ]
Ryan, Fiona [1 ]
Watson, Chris J. [3 ]
Ledwidge, Mark [1 ,2 ]
McDonald, Kenneth [1 ,2 ]
机构
[1] St Vincents Univ, STOP HF Unit, Healthcare Grp, Dublin 4, Ireland
[2] Univ Coll Dublin, Sch Med, Dublin, Ireland
[3] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland
关键词
COLLABORATIVE CARE; BIOMARKERS;
D O I
10.1002/ejhf.1661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:378 / 380
页数:3
相关论文
共 50 条
  • [1] New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure (vol 22, pg 378, 2020)
    McClelland, S.
    Zhou, S.
    O'Connell, E.
    Gallagher, J.
    Ryan, F.
    Watson, C. J.
    Ledwidge, M.
    McDonald, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (06) : 1056 - 1056
  • [2] Natriuretic Peptide-Based Screening and Collaborative Care for Heart Failure The STOP-HF Randomized Trial
    Ledwidge, Mark
    Gallagher, Joseph
    Conlon, Carmel
    Tallon, Elaine
    O'Connell, Eoin
    Dawkins, Ian
    Watson, Chris
    O'Hanlon, Rory
    Bermingham, Margaret
    Patle, Anil
    Badabhagni, Mallikarjuna R.
    Murtagh, Gillian
    Voon, Victor
    Tilson, Leslie
    Barry, Michael
    McDonald, Laura
    Maurer, Brian
    McDonald, Kenneth
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (01): : 66 - 74
  • [3] BASELINE B-TYPE NATRIURETIC PEPTIDE IS THE STRONGEST PREDICTOR OF TRANSITION TO STAGE C HEART FAILURE IN AN AT-RISK POPULATION; RESULTS FROM THE STOP-HF PREVENTION PROGRAMME
    Mc Cleland, S.
    Zhou, S.
    O'Connell, E.
    Ledwidge, M.
    Murphy, R.
    Watson, C.
    Healy, L.
    Ryan, F.
    Gallagher, J.
    McDonald, K.
    [J]. HEART, 2018, 104 : A3 - A4
  • [4] Baseline B-type natriuretic peptide is the strongest predictor of transition to stage C heart failure in an at-risk population; Results from the STOP-HF prevention programme
    McClelland, S.
    Healy, L.
    Murphy, R.
    Zhou, S.
    Gallagher, J.
    Watson, C.
    Ledwidge, M.
    McDonald, K.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1198 - 1198
  • [5] Baseline B-type natriuretic peptide is the strongest predictor of transition to stage C heart failure in an at-risk population; Results from the STOP-HF prevention programme
    Mcclelland, S.
    Healy, L.
    Murphy, R.
    Zhou, S.
    Gallagher, J.
    Watson, C.
    Ledwidge, M.
    Mcdonald, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 13 - 13
  • [6] Progression of left atrial volume index in a population at risk for heart failure: a substudy of the STOP-HF (St Vincents Screening TO Prevent Heart Failure) trialS
    Collier, Patrick
    Watson, Chris J.
    Waterhouse, Deidre F.
    Dawkins, Ian R.
    Patle, Anil K.
    Horgan, Stephen
    Conlon, Carmel M.
    O'Hanlon, Rory
    Baugh, John A.
    Ledwidge, Mark T.
    McDonald, Kenneth
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (09) : 957 - 964
  • [7] Predictive Value of Depressive Symptoms and B-Type Natriuretic Peptide for New-Onset Heart Failure and Mortality
    van den Broek, Krista C.
    deFilippi, Christopher R.
    Christenson, Robert H.
    Seliger, Stephen L.
    Gottdiener, John S.
    Kop, Willem J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (05): : 723 - 729
  • [8] Transcriptomic biomarkers for individual risk assessment in new-onset heart failure
    Heidecker, Bettina
    Kasper, Edward K.
    Wittstein, Ilan S.
    Champion, Hunter C.
    Breton, Elayne
    Russell, Stuart D.
    Kittleson, Michelle M.
    Baughman, Kenneth L.
    Hare, Joshua M.
    [J]. CIRCULATION, 2008, 118 (03) : 238 - 246
  • [9] Estimated pulse wave velocity and risk of new-onset heart failure
    Ji, Chunpeng
    Wang, Guodong
    Huang, Zhe
    Zhu, Chenrui
    Liu, Yan
    [J]. ESC HEART FAILURE, 2024, 11 (04): : 2120 - 2128
  • [10] Proenkephalin and the risk of new-onset heart failure: data from PREVEND
    Emmens, J. E.
    Ter Maaten, J. M.
    Brouwers, F. P.
    Kieneker, L. M.
    Damman, K.
    Hartmann, O.
    Schulte, J.
    Bakker, S. J. L.
    De Boer, R. A.
    Voors, A. A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 164 - 165